GHISLAINE MAXWELL ACCT.
For the Period 8/I/I I to 8/31/11
Account Summary
Beginning Ending Change Estimated Current Asset Allocation
Asset Allocation Market Value Market Value In Value Annual Income Allocation
Equity 323,294.00 318,597.00 (4,697.00) 15,632.50 11%
Alternative Assets 59,860.00 60,790.00 930.00 2%
Cash 8 Fixed Income 2,236,346.58 2,611,943.13 375,596.55 78,448.27 87% Alternative
Market Value 32,619,600.69 32,991,330.13 $371,829.66 $94.080.77 100% Assets
Accruals 18,160 72 16,082.11 (2,078.61)
Market Value with Accruals $2,637,661.30 $3,007,412.24 3369,760.94
Cases
Fixed ASCOTS
Current Year-to-Date
Portfolio Activity Period Value Value
Beginning Market Value 2,619,600.68 1946,279.39
Contributions 545,420.04 805,513.35
1/1.4thdrawals 8 Fees (150,321.57) (152.299.92)
Securities Transferred In 1,012,740.42 7,310,511.28
Securities Transferred Out (1,012,418.82) (7,562,372.85)
Net Contributions/Withdrawals 0396,420.07 $401,361.86
Income 8 Distributions 7,148.45 56,338.93
Change In Investment Value (30,738.97) 587,359.95
Ending Market Value 32,991,330.13 32,991,330.13
Accruals 16,062.11 16,082.11
Market Value with Accruals $3,007,412.24 33,007,412.24
JP Morgan Page 2 of 24
Confidential Treatment Requested by JPMorgan JPM-SDNY-00048093
Chase
CONFIDENTIAL SDNY_GM_00317291
EFTA01520757